PRODUCT NAME:

Product Name: Tacrolimus CLIA Kit (Chemiluminescence Immunoassay) Abbreviation: FK506 

INTENDED USE:

Tacrolimus CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection of Tacrolimus (FK506) in human whole blood specimen. This product is intended to be used by laboratory professional workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical observations, patient history, other laboratory parameters, and epidemiological information. Tacrolimus (FK506) is a commonly used immunosuppressive drug for the treatment of immune rejection after organ transplantation. The pharmacokinetics of tacrolimus varies widely among individuals in organ transplant patients. The safe concentration range of tacrolimus is narrow, and the differences between individuals are large. Too low blood drug concentration cannot play an effective therapeutic effect, and higher than its effective blood drug concentration may cause serious toxic and side effects, including renal toxicity, neurotoxicity, hypertension, insomnia and nausea, etc. Therefore, the monitoring of tacrolimus blood concentration is of great significance for guiding the clinical rational drug use after transplantation.